Lee Ainslie Stryker Corp Transaction History

Maverick Capital LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$271.49 - $305.09 $965,961 - $1.09 Million	-3,558 Reduced 70.08%	1,519 $463,000
Q1 2023 May 15, 2023	BUY	$246.13 - $285.47 $1.25 Million - $1.45 Million	5,077 New	5,077 $1.45 Million
Q3 2021 Nov 15, 2021	SELL	$248.9 - $280.09 $494,564 - $556,538	-1,987 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$242.95 - $267.0 $1.47 Million - $1.61 Million	-6,043 Reduced 75.26%	1,987 $516,000
Q1 2021 May 17, 2021	BUY	$221.01 - $248.82 $1.77 Million - $2 Million	8,030 New	8,030 $1.96 Million
Q3 2020 Nov 16, 2020	SELL	$177.77 - $215.81 $905,560 - $1.1 Million	-5,094 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$144.67 - $207.03 $736,948 - $1.05 Million	5,094 New	5,094 $918,000

2,230

285M

1.35M

1.6M

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $146B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.